サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：精密医療における人工知能（AI）の世界市場：2023-2030年
市場調査レポート
商品コード
1350994

精密医療における人工知能（AI）の世界市場：2023-2030年

Global Artificial Intelligence (AI) in Precision Medicine Market 2023-2030

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
精密医療における人工知能（AI）の世界市場：2023-2030年
出版日: 2023年08月20日
発行: Orion Market Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の精密医療におけるAI市場は、予測期間中（2023-2030年）にCAGR 19.2％で成長すると予測されています。精密医療は、がん、遺伝性疾患、その他の複雑な疾患の診断、治療、予防を導くために、個人に固有の臨床情報、分子情報、生活習慣情報を利用します。市場成長の主な原動力は、個別化医療の普及に伴う研究開発投資の増加です。例えば、米国国立生物工学情報研究所（NCBI）は、新薬の発見と開発にかかるコストは約30億米ドルで、臨床試験に達したすべての化合物を考慮した場合の承認率は13%に近いと推定しています。

さらに、主要な市場組織間の提携などの戦略的イニシアチブも、世界中で業界の成長を促進する上で重要な役割を果たしています。例えば、2023年2月、AIと精密医療を専門とするTempus社とファイザーとの複数年にわたる戦略的提携が明らかになっています。この提携は、今後行われる医薬品研究におけるAIと機械学習（ML）の利用を促進することを目的としています。

セグメント別の展望

神経学サブセグメントが精密医療におけるAI世界市場でかなりのシェアを占めると予想される

治療の中でも神経学サブセグメントは、精密医療における人工知能の世界市場でかなりのシェアを占めると予測されています。このセグメントの成長は、スクリーニングの選択肢を提供し、一刻を争う検出/診断を実施し、患者固有の臨床的-遺伝的-生物学的特性やリスク要因に治療計画を適応させることができる神経学や精神医学のアプローチの重要性が高まっていることに起因しています。また、大手企業間の提携もセグメント成長に大きく貢献しています。例えば、2021年12月、TheraPanaceaとBiogen Inc.は、多くの神経治療分野に焦点を当てた提携を発表しました。その目的は、MLとAIアナリティクスを用いたデジタルヘルスソリューションの開発であり、これにより患者ケアの改善、創薬の加速、神経疾患の根底にある病態の理解の促進が期待できます。

地域別展望

精密医療における人工知能の世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）など、地域によってさらに細分化されます。中でもアジア太平洋地域は、AIベースのヘルスケア技術に注力し、個人投資家とベンチャーキャピタルの両方から資金提供という形で支援を受けている新興企業の数が増加していることから、世界全体で大きなシェアを占めると予想されます。主な市場プレイヤーには、Novo Nordisk A/S、GEヘルスケア、NVIDIA Corp.、Alphabet Inc.、IBM Corp.BioXcel Therapeutics Inc.、Enlitic Inc.、AstraZenecaなどです。

精密医療におけるAIの世界市場では北米地域が大幅なCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。強力なヘルスケアインフラ、先進的なデバイスの開発に対する大手企業の投資の増加、低侵襲処置の高い採用率、払い戻しの利用可能性、高齢化、COVID-19パンデミックの発症と組み合わされた高い医療費、研究活動の増加などが、この地域の成長の要因となっています。個々の患者にとって最も効果的な治療法は、ゲノムデータを含む大量のデータを個々の患者の治療計画に取り入れる革新的な手法を用いた様々な精密医療研究所によって決定されます。例えば、2023年7月、コロラド小児医療機関（Children's Colorado）が精密医療研究所を立ち上げ、専門医が施設全体の患者ケアに精密医療をより効果的に取り入れることを可能にしました。

効果的な学習型ヘルスケアシステムには、医療ITの導入、患者の積極的な関与、医療機関内外の医療専門家と学者の連携、知識交換を奨励する政策が必要です。新しい技術（オミックスなど）に目を向け、支援する政府のイニシアチブは、病気の診断、予後、治療において著しい進歩を遂げるのに役立っています。これらはすべて、同地域のヘルスケア産業における市場拡大とAI導入の促進に大きく寄与しています。例えば、2022年6月、FDAがコミュニティの研究開発のために設計したクラウドベースのプラットフォームであるPrecision FDAは、世界中のユーザーがNGS処理のための確立されたバイオインフォマティクス手法と新しいバイオインフォマティクス手法の両方をテスト、試験、検証するためのデータとツールを交換することを可能にします。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Intel Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Microsoft Corp.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Sanofi S.A.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 精密医療における人工知能（AI）の世界市場：コンポーネント別
    • ハードウェア
    • ソフトウェアとサービス
  • 精密医療における人工知能（AI）の世界市場：治療別
    • 腫瘍学
    • 神経学
    • 循環器
    • 呼吸器
  • 精密医療における人工知能（AI）の世界市場：用途別
    • 創薬と再利用
    • 臨床研究試験
    • 個別化医療

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Alphabet Inc.
  • AstraZeneca
  • Atomwise Inc.
  • Berg LLC
  • BioXcel Therapeutics Inc.
  • Enlitic Inc.
  • GE Healthcare
  • IBM Corp.
  • Insilico Medicine
  • Modernizing Medicine Inc.
  • Novo Nordisk A/S
  • NVIDIA Corp.
  • Sensely Inc.
  • Tempus
  • Zephyr AI
図表

LIST OF TABLES

  • 1. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2022-2030 ($ MILLION)
  • 2. GLOBAL HARDWARE FOR AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL SOFTWARE AND SERVICES FOR AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 5. GLOBAL AI IN PRECISION MEDICINE FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 6. GLOBAL AI IN PRECISION MEDICINE FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 7. GLOBAL AI IN PRECISION MEDICINE FOR CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 8. GLOBAL AI IN PRECISION MEDICINE FOR RESPIRATORY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL AI IN PRECISION MEDICINE FOR DRUG DISCOVERY & REPURPOSING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 11. GLOBAL AI IN PRECISION MEDICINE FOR CLINICAL RESEARCH TRIAL MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 12. GLOBAL AI IN PRECISION MEDICINE FOR PERSONALIZED MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 13. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. EUROPEAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. ASIA- PACIFIC AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AI IN PRECISION MEDICINE MARKET SHARE BY COMPONENT, 2022 VS 2030 (%)
  • 2. GLOBAL HARDWARE FOR AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL SOFTWARE AND SERVICES FOR AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022 VS 2030 (%)
  • 5. GLOBAL AI IN PRECISION MEDICINE FOR ONCOLOGY PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AI IN PRECISION MEDICINE FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AI IN PRECISION MEDICINE FOR CARDIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AI IN PRECISION MEDICINE FOR RESPIRATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AI IN PRECISION MEDICINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL AI IN PRECISION MEDICINE FOR DRUG DISCOVERY & REPURPOSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL AI IN PRECISION MEDICINE FOR CLINICAL RESEARCH TRIAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AI IN PRECISION MEDICINE FOR PERSONALIZED MEDICINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL AI IN PRECISION MEDICINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AI IN PRECISION MEDICINE MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027588

Title: Global Artificial Intelligence (AI) in Precision Medicine Market Size, Share & Trends Analysis Report by Component (Hardware and Software & Services), by Treatment (Oncology, Neurology, Cardiology, and Respiratory), and by Application (Drug Discovery & Repurposing, Clinical Research Trial, and Personalized Medicine),Forecast Period (2023-2030).

The global AI in precision medicine market is anticipated to grow at a CAGR of 19.2% during the forecast period (2023-2030). Precision medicine uses an individual's unique clinical, molecular and lifestyle information to guide disease diagnosis, treatment and prevention for cancer, inherited diseases and other complex disorders. The market growth is primarily driven by the increasing investments in R&D along with the rising adoption of personalized medications. For instance, the National Institute of Biotechnology Information (NCBI) estimated that the cost of discovering and developing a new drug is around $3 billion, with an approval rate close to 13% when considering all the compounds that reached clinical trials.

Moreover, strategic initiatives such as collaborations among the key market organization also play an important role in driving the industry's growth around the globe. For instance, in February 2023, a multi-year, strategic partnership between Tempus, a company that specializes in AI and precision medicine, and Pfizer has been revealed. The collaboration aims to advance the use of AI and machine learning (ML) in the forthcoming pharmaceutical research.

Segmental Outlook

The global AI in precision medicine market is segmented on the component, treatment, and application. Based on the component, the market is sub-segmented into hardware and software and services. Based on the treatment, the market is sub-segmented into oncology, neurology, cardiology, and respiratory. Further, on the basis of application, the market is sub-segmented into drug discovery & repurposing, clinical research trials, and personalized medicine. Among the application, the sub-segment is anticipated to hold a considerable share of the market owing to the rising artificial intelligence algorithms in precision medicine and will enable a fully individualized approach to drug design, ultimately influencing clinical practice. Drug development is increasingly adapted to the heterogeneity of patients across their molecular profiles.

The Neurology Sub-Segment is Anticipated to Hold a Considerable Share of the Global AI in Precision Medicine Market

Among the treatment, the neurology sub-segment is expected to hold a considerable share of the global artificial intelligence in the precision medicine market. The segmental growth is attributed to the increasing importance of neurology and psychiatry approaches that could offer screening options, implement time-sensitive detection/diagnosis, and adapt treatment plans to a patient's unique clinical-genetic-biological characteristics and risk factors. Significant contributions to segmental growth are also made through collaborations between major companies. For instance, in December 2021, TheraPanacea and Biogen Inc. announced a partnership focused on a number of neurotherapeutic areas. The goal is to develop digital health solutions using ML and AI analytics that could improve patient care, accelerate drug discovery, and further our understanding of the pathologies that underlie neurological disorders.

Regional Outlook

The global artificial intelligence in precision medicine market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia- Pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing number of startups that focus on AI-based healthcare technology and are getting support in the form of funding from both individual investors and venture capitalists. The key market players include Novo Nordisk A/S, GE Healthcare, NVIDIA Corp., Alphabet Inc., IBM Corp. BioXcel Therapeutics Inc., Enlitic Inc., and AstraZeneca.

The North America Region is Expected to Grow at a Significant CAGR in the Global AI in Precision Medicine Market

Among all regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. Strong healthcare infrastructure, increasing investment from major players in the development of advanced devices, a high adoption rate of minimally invasive procedures, the availability of reimbursements, an ageing population, high healthcare spending combined with the onset of the COVID-19 pandemic, and an increase in research activities are all factors that contribute to the region's growth. The most effective method of therapy for each patient is determined by various precision medicine institute using innovative methods to incorporate large quantities of data, including genomic data, into each individual patient's care plan. For instance, in July 2023, the Precision Medicine Institute has been launched by Children's Institution Colorado (Children's Colorado), enabling specialists to more effectively incorporate precision medicine into patient care across the institution.

An effective learning healthcare system necessitates the implementation of health IT, active patient involvement, the collaboration between healthcare professionals and academics inside and across institutions, and policies that encourage knowledge exchange. Government initiatives that are supportive and look into new technologies (such omics) are helping to advance significant advancements in disease diagnosis, prognosis, and therapy. They all contributed significantly to market expansion and quickening the adoption of AI in the healthcare industry in the region. For instance, in June 2022, Precision FDA, a cloud-based platform designed by the FDA for community research and development, enables users from around the globe to exchange data and tools to test, pilot, and verify both established and novel bioinformatics methodologies for NGS processing.

Market Players Outlook

The major companies serving AI in the precision medicine market include: BioXcel Therapeutics Inc., Intel Corp., Microsoft Corp., Modernizing Medicine Inc., Sanofi S.A., NVIDIA Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, the US-based precision medicine company Tempus and GSK plc signed a three-year collaboration agreement. This agreement grants GSK access to Tempus' AI-enabled platform and repository of identified patient data. Leveraging its industry AI and ML capabilities, GSK will work with Tempus to improve clinical trial design, EXPEDITE enrolment processes, and identify therapeutic targets.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global AI in the precision medicine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Intel Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Microsoft Corp.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Sanofi S.A.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial Intelligence (AI) in Precision Medicine Market by Component
    • 4.1.1. Hardware
    • 4.1.2. Software and Services
  • 4.2. Global Artificial Intelligence (AI) in Precision Medicine Market by Treatment
    • 4.2.1. Oncology
    • 4.2.2. Neurology
    • 4.2.3. Cardiology
    • 4.2.4. Respiratory
  • 4.3. Global Artificial Intelligence (AI) in Precision Medicine Market by Application
    • 4.3.1. Drug Discovery & Repurposing
    • 4.3.2. Clinical Research Trial
    • 4.3.3. Personalized Medicine

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Alphabet Inc.
  • 6.2. AstraZeneca
  • 6.3. Atomwise Inc.
  • 6.4. Berg LLC
  • 6.5. BioXcel Therapeutics Inc.
  • 6.6. Enlitic Inc.
  • 6.7. GE Healthcare
  • 6.8. IBM Corp.
  • 6.9. Insilico Medicine
  • 6.10. Modernizing Medicine Inc.
  • 6.11. Novo Nordisk A/S
  • 6.12. NVIDIA Corp.
  • 6.13. Sensely Inc.
  • 6.14. Tempus
  • 6.15. Zephyr AI